Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 566

1.

Biventricular pacemaker therapy improves exercise capacity in patients with non-obstructive hypertrophic cardiomyopathy via augmented diastolic filling on exercise.

Ahmed I, Loudon BL, Abozguia K, Cameron D, Shivu GN, Phan TT, Maher A, Stegemann B, Chow A, Marshall H, Nightingale P, Leyva F, Vassiliou VS, McKenna WJ, Elliott P, Frenneaux MP.

Eur J Heart Fail. 2020 Jan 23. doi: 10.1002/ejhf.1722. [Epub ahead of print]

PMID:
31975494
2.

RNA sequencing-based transcriptome profiling of cardiac tissue implicates novel putative disease mechanisms in FLNC-associated arrhythmogenic cardiomyopathy.

Hall CL, Gurha P, Sabater-Molina M, Asimaki A, Futema M, Lovering RC, Suárez MP, Aguilera B, Molina P, Zorio E, Coarfa C, Robertson MJ, Cheedipudi SM, Ng KE, Delaney P, Hernández JP, Pastor F, Gimeno JR, McKenna WJ, Marian AJ, Syrris P.

Int J Cardiol. 2020 Mar 1;302:124-130. doi: 10.1016/j.ijcard.2019.12.002. Epub 2019 Dec 6.

3.

2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: Executive summary.

Towbin JA, McKenna WJ, Abrams DJ, Ackerman MJ, Calkins H, Darrieux FCC, Daubert JP, de Chillou C, DePasquale EC, Desai MY, Estes NAM 3rd, Hua W, Indik JH, Ingles J, James CA, John RM, Judge DP, Keegan R, Krahn AD, Link MS, Marcus FI, McLeod CJ, Mestroni L, Priori SG, Saffitz JE, Sanatani S, Shimizu W, van Tintelen JP, Wilde AAM, Zareba W.

Heart Rhythm. 2019 Nov;16(11):e373-e407. doi: 10.1016/j.hrthm.2019.09.019.

PMID:
31676023
4.

Novel strategies to evaluate the effectiveness of heart failure services.

McKenna WJ, Montoro-López MN.

Rev Esp Cardiol (Engl Ed). 2020 Mar;73(3):200-204. doi: 10.1016/j.rec.2019.09.009. Epub 2019 Oct 24. English, Spanish. No abstract available.

PMID:
31668638
5.

Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis.

Corrado D, van Tintelen PJ, McKenna WJ, Hauer RNW, Anastastakis A, Asimaki A, Basso C, Bauce B, Brunckhorst C, Bucciarelli-Ducci C, Duru F, Elliott P, Hamilton RM, Haugaa KH, James CA, Judge D, Link MS, Marchlinski FE, Mazzanti A, Mestroni L, Pantazis A, Pelliccia A, Marra MP, Pilichou K, Platonov PGA, Protonotarios A, Rampazzo A, Saffitz JE, Saguner AM, Schmied C, Sharma S, Tandri H, Te Riele ASJM, Thiene G, Tsatsopoulou A, Zareba W, Zorzi A, Wichter T, Marcus FI, Calkins H; International Experts .

Eur Heart J. 2019 Oct 21. pii: ehz669. doi: 10.1093/eurheartj/ehz669. [Epub ahead of print] No abstract available.

PMID:
31637441
6.

Filamin C variants are associated with a distinctive clinical and immunohistochemical arrhythmogenic cardiomyopathy phenotype.

Hall CL, Akhtar MM, Sabater-Molina M, Futema M, Asimaki A, Protonotarios A, Dalageorgou C, Pittman AM, Suarez MP, Aguilera B, Molina P, Zorio E, Hernández JP, Pastor F, Gimeno JR, Syrris P, McKenna WJ.

Int J Cardiol. 2019 Oct 8. pii: S0167-5273(19)33019-0. doi: 10.1016/j.ijcard.2019.09.048. [Epub ahead of print]

7.

Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy.

Gigli M, Merlo M, Graw SL, Barbati G, Rowland TJ, Slavov DB, Stolfo D, Haywood ME, Dal Ferro M, Altinier A, Ramani F, Brun F, Cocciolo A, Puggia I, Morea G, McKenna WJ, La Rosa FG, Taylor MRG, Sinagra G, Mestroni L.

J Am Coll Cardiol. 2019 Sep 17;74(11):1480-1490. doi: 10.1016/j.jacc.2019.06.072.

PMID:
31514951
8.

Myoarchitectural disarray of hypertrophic cardiomyopathy begins pre-birth.

Garcia-Canadilla P, Cook AC, Mohun TJ, Oji O, Schlossarek S, Carrier L, McKenna WJ, Moon JC, Captur G.

J Anat. 2019 Nov;235(5):962-976. doi: 10.1111/joa.13058. Epub 2019 Jul 26.

9.

Definition and treatment of arrhythmogenic cardiomyopathy: an updated expert panel report.

Elliott PM, Anastasakis A, Asimaki A, Basso C, Bauce B, Brooke MA, Calkins H, Corrado D, Duru F, Green KJ, Judge DP, Kelsell D, Lambiase PD, McKenna WJ, Pilichou K, Protonotarios A, Saffitz JE, Syrris P, Tandri H, Te Riele A, Thiene G, Tsatsopoulou A, van Tintelen JP.

Eur J Heart Fail. 2019 Aug;21(8):955-964. doi: 10.1002/ejhf.1534. Epub 2019 Jun 18.

10.

Understanding the Myocardial Architecture of Hypertrophic Cardiomyopathy for Clinical Care.

McKenna WJ, Moon JC, Sulaiman A.

J Am Coll Cardiol. 2019 May 28;73(20):2503-2505. doi: 10.1016/j.jacc.2019.03.466. No abstract available.

PMID:
31118143
11.

Risk score for the exclusion of arrhythmic events in arrhythmogenic right ventricular cardiomyopathy at first presentation.

Vischer AS, Castelletti S, Syrris P, Bastiaenen R, Miles C, Akdis D, Denhaerynck K, Jacoby D, Saguner AM, Krahn AD, Behr ER, McKenna WJ, Pantazis A.

Int J Cardiol. 2019 Sep 1;290:100-105. doi: 10.1016/j.ijcard.2019.04.090. Epub 2019 May 1.

PMID:
31104822
12.

2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy.

Towbin JA, McKenna WJ, Abrams DJ, Ackerman MJ, Calkins H, Darrieux FCC, Daubert JP, de Chillou C, DePasquale EC, Desai MY, Estes NAM 3rd, Hua W, Indik JH, Ingles J, James CA, John RM, Judge DP, Keegan R, Krahn AD, Link MS, Marcus FI, McLeod CJ, Mestroni L, Priori SG, Saffitz JE, Sanatani S, Shimizu W, van Tintelen JP, Wilde AAM, Zareba W.

Heart Rhythm. 2019 Nov;16(11):e301-e372. doi: 10.1016/j.hrthm.2019.05.007. Epub 2019 May 9.

PMID:
31078652
13.

Prediction of ventricular arrhythmia and sudden death in arrhythmogenic right ventricular cardiomyopathy.

McKenna WJ, Asaad NA, Jacoby DL.

Eur Heart J. 2019 Jun 14;40(23):1859-1861. doi: 10.1093/eurheartj/ehz195. No abstract available.

PMID:
30977786
14.

Heart failure in patients with arrhythmogenic right ventricular cardiomyopathy: Genetic characteristics.

Vischer AS, Castelletti S, Syrris P, McKenna WJ, Pantazis A.

Int J Cardiol. 2019 Jul 1;286:99-103. doi: 10.1016/j.ijcard.2019.01.065. Epub 2019 Jan 27.

PMID:
30765282
15.

Effect of Trimetazidine Dihydrochloride Therapy on Exercise Capacity in Patients With Nonobstructive Hypertrophic Cardiomyopathy: A Randomized Clinical Trial.

Coats CJ, Pavlou M, Watkinson OT, Protonotarios A, Moss L, Hyland R, Rantell K, Pantazis AA, Tome M, McKenna WJ, Frenneaux MP, Omar R, Elliott PM.

JAMA Cardiol. 2019 Mar 1;4(3):230-235. doi: 10.1001/jamacardio.2018.4847.

16.

Proteomic Analysis of the Myocardium in Hypertrophic Obstructive Cardiomyopathy.

Coats CJ, Heywood WE, Virasami A, Ashrafi N, Syrris P, Dos Remedios C, Treibel TA, Moon JC, Lopes LR, McGregor CGA, Ashworth M, Sebire NJ, McKenna WJ, Mills K, Elliott PM.

Circ Genom Precis Med. 2018 Dec;11(12):e001974. doi: 10.1161/CIRCGEN.117.001974.

PMID:
30562113
17.

Lamin mutation location predicts cardiac phenotype severity: combined analysis of the published literature.

Captur G, Arbustini E, Syrris P, Radenkovic D, O'Brien B, Mckenna WJ, Moon JC.

Open Heart. 2018 Oct 25;5(2):e000915. doi: 10.1136/openhrt-2018-000915. eCollection 2018.

18.

Loss-of-function desmoplakin I and II mutations underlie dominant arrhythmogenic cardiomyopathy with a hair and skin phenotype.

Maruthappu T, Posafalvi A, Castelletti S, Delaney PJ, Syrris P, O'Toole EA, Green KJ, Elliott PM, Lambiase PD, Tinker A, McKenna WJ, Kelsell DP.

Br J Dermatol. 2019 May;180(5):1114-1122. doi: 10.1111/bjd.17388. Epub 2019 Jan 2.

PMID:
30382575
19.

Ablation compared with drug therapy for recurrent ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy: Results from a multicenter study.

Mahida S, Venlet J, Saguner AM, Kumar S, Baldinger SH, AbdelWahab A, Tedrow UB, Castelletti S, Pantazis A, John RM, McKenna WJ, Lambiase PD, Duru F, Sapp JL, Zeppenfeld K, Stevenson WG.

Heart Rhythm. 2019 Apr;16(4):536-543. doi: 10.1016/j.hrthm.2018.10.016. Epub 2018 Oct 24.

PMID:
30366162
20.

Ethnic differences in out-of-hospital cardiac arrest among Middle Eastern Arabs and North African populations living in Qatar.

Irfan FB, Castren M, Bhutta ZA, George P, Qureshi I, Thomas SH, Pathan SA, Alinier G, Shaikh LA, Suwaidi JA, Singh R, Shuaib A, Tariq T, McKenna WJ, Cameron PA, Djarv T.

Ethn Health. 2018 Oct 10:1-10. doi: 10.1080/13557858.2018.1530736. [Epub ahead of print]

PMID:
30303400
21.

No major role for rare plectin variants in arrhythmogenic right ventricular cardiomyopathy.

Hoorntje ET, Posafalvi A, Syrris P, van der Velde KJ, Bolling MC, Protonotarios A, Boven LG, Amat-Codina N, Groeneweg JA, Wilde AA, Sobreira N, Calkins H, Hauer RNW, Jonkman MF, McKenna WJ, Elliott PM, Sinke RJ, van den Berg MP, Chelko SP, James CA, van Tintelen JP, Judge DP, Jongbloed JDH.

PLoS One. 2018 Aug 30;13(8):e0203078. doi: 10.1371/journal.pone.0203078. eCollection 2018.

22.

Frequency of genetic variants associated with arrhythmogenic right ventricular cardiomyopathy in the genome aggregation database.

Hall CL, Sutanto H, Dalageorgou C, McKenna WJ, Syrris P, Futema M.

Eur J Hum Genet. 2018 Sep;26(9):1312-1318. doi: 10.1038/s41431-018-0169-4. Epub 2018 May 25.

23.

Arrhythmogenic right ventricular cardiomyopathy in Boxer dogs: the diagnosis as a link to the human disease.

Vischer AS, Connolly DJ, Coats CJ, Fuentes VL, McKenna WJ, Castelletti S, Pantazis AA.

Acta Myol. 2017 Sep 1;36(3):135-150. eCollection 2017 Sep.

24.

Lamin and the heart.

Captur G, Arbustini E, Bonne G, Syrris P, Mills K, Wahbi K, Mohiddin SA, McKenna WJ, Pettit S, Ho CY, Muchir A, Gissen P, Elliott PM, Moon JC.

Heart. 2018 Mar;104(6):468-479. doi: 10.1136/heartjnl-2017-312338. Epub 2017 Nov 25. Review.

PMID:
29175975
25.

Response by Andrews et al to Letter Regarding Article, "Electrical and Structural Substrate of Arrhythmogenic Right Ventricular Cardiomyopathy Determined Using Noninvasive Electrocardiographic Imaging and Late Gadolinium Magnetic Resonance Imaging".

Andrews CM, Srinivasan NT, Rosmini S, Bulluck H, Orini M, Jenkins S, Pantazis A, McKenna WJ, Moon JC, Lambiase PD, Rudy Y.

Circ Arrhythm Electrophysiol. 2017 Oct;10(10). pii: e005768. doi: 10.1161/CIRCEP.117.005768. No abstract available.

26.

Classification, Epidemiology, and Global Burden of Cardiomyopathies.

McKenna WJ, Maron BJ, Thiene G.

Circ Res. 2017 Sep 15;121(7):722-730. doi: 10.1161/CIRCRESAHA.117.309711. Review.

PMID:
28912179
27.

Electrical and Structural Substrate of Arrhythmogenic Right Ventricular Cardiomyopathy Determined Using Noninvasive Electrocardiographic Imaging and Late Gadolinium Magnetic Resonance Imaging.

Andrews CM, Srinivasan NT, Rosmini S, Bulluck H, Orini M, Jenkins S, Pantazis A, McKenna WJ, Moon JC, Lambiase PD, Rudy Y.

Circ Arrhythm Electrophysiol. 2017 Jul;10(7). pii: e005105. doi: 10.1161/CIRCEP.116.005105.

28.

Desmoplakin missense and non-missense mutations in arrhythmogenic right ventricular cardiomyopathy: Genotype-phenotype correlation.

Castelletti S, Vischer AS, Syrris P, Crotti L, Spazzolini C, Ghidoni A, Parati G, Jenkins S, Kotta MC, McKenna WJ, Schwartz PJ, Pantazis A.

Int J Cardiol. 2017 Dec 15;249:268-273. doi: 10.1016/j.ijcard.2017.05.018. Epub 2017 May 10.

PMID:
28527814
29.

Relationship between aetiology and left ventricular systolic dysfunction in hypertrophic cardiomyopathy.

Rosmini S, Biagini E, O'Mahony C, Bulluck H, Ruozi N, Lopes LR, Guttmann O, Reant P, Quarta CC, Pantazis A, Tome-Esteban M, Mckenna WJ, Rapezzi C, Elliott PM.

Heart. 2017 Feb 15;103(4):300-306. doi: 10.1136/heartjnl-2016-310138. Epub 2016 Oct 24.

PMID:
27798053
30.

Predictors of atrial fibrillation in hypertrophic cardiomyopathy.

Guttmann OP, Pavlou M, O'Mahony C, Monserrat L, Anastasakis A, Rapezzi C, Biagini E, Gimeno JR, Limongelli G, Garcia-Pavia P, McKenna WJ, Omar RZ, Elliott PM; Hypertrophic Cardiomyopathy Outcomes Investigators.

Heart. 2017 May;103(9):672-678. doi: 10.1136/heartjnl-2016-309672. Epub 2016 Oct 28.

PMID:
27794017
31.

Update on hypertrophic cardiomyopathy and a guide to the guidelines.

Sen-Chowdhry S, Jacoby D, Moon JC, McKenna WJ.

Nat Rev Cardiol. 2016 Nov;13(11):651-675. doi: 10.1038/nrcardio.2016.140. Epub 2016 Sep 29. Review.

PMID:
27681577
32.

The embryological basis of subclinical hypertrophic cardiomyopathy.

Captur G, Ho CY, Schlossarek S, Kerwin J, Mirabel M, Wilson R, Rosmini S, Obianyo C, Reant P, Bassett P, Cook AC, Lindsay S, McKenna WJ, Mills K, Elliott PM, Mohun TJ, Carrier L, Moon JC.

Sci Rep. 2016 Jun 21;6:27714. doi: 10.1038/srep27714.

33.

Inverted U-Shaped Relation Between the Risk of Sudden Cardiac Death and Maximal Left Ventricular Wall Thickness in Hypertrophic Cardiomyopathy.

O'Mahony C, Jichi F, Monserrat L, Ortiz-Genga M, Anastasakis A, Rapezzi C, Biagini E, Gimeno JR, Limongelli G, McKenna WJ, Omar RZ, Elliott PM; Hypertrophic Cardiomyopathy Outcomes Investigators*.

Circ Arrhythm Electrophysiol. 2016 Jun;9(6). pii: e003818. doi: 10.1161/CIRCEP.115.003818.

PMID:
27217341
34.

Survival After Heart Transplantation in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.

DePasquale EC, Cheng RK, Deng MC, Nsair A, McKenna WJ, Fonarow GC, Jacoby DL.

J Card Fail. 2017 Feb;23(2):107-112. doi: 10.1016/j.cardfail.2016.04.020. Epub 2016 May 3.

PMID:
27154489
35.

The ventricular ectopic QRS interval (VEQSI): Diagnosis of arrhythmogenic right ventricular cardiomyopathy in patients with incomplete disease expression.

Bastiaenen R, Pantazis A, Gonna H, Chis-Ster I, Castelletti S, Batchvarov VN, Domenichini G, Coccolo F, Boriani G, McKenna WJ, Behr ER, Gallagher MM.

Heart Rhythm. 2016 Jul;13(7):1504-12. doi: 10.1016/j.hrthm.2016.03.039. Epub 2016 Mar 22.

PMID:
27016477
36.

Response to Letter Regarding Article, "Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: An International Task Force Consensus Statement".

Corrado D, Wichter T, Link MS, Hauer R, Marchlinski F, Anastasakis A, Bauce B, Basso C, Brunckhorst C, Tsatsopoulou A, Tandri H, Paul M, Schmied C, Pelliccia A, Duru F, Estes NA 3rd, McKenna WJ, Thiene G, Marcus FI, Calkins H.

Circulation. 2016 Mar 15;133(11):e437-8. doi: 10.1161/CIRCULATIONAHA.116.020660. No abstract available.

37.

Global longitudinal strain is associated with heart failure outcomes in hypertrophic cardiomyopathy.

Reant P, Mirabel M, Lloyd G, Peyrou J, Lopez Ayala JM, Dickie S, Bulluck H, Captur G, Rosmini S, Guttmann O, Demetrescu C, Pantazis A, Tome-Esteban M, Moon JC, Lafitte S, McKenna WJ.

Heart. 2016 May 15;102(10):741-7. doi: 10.1136/heartjnl-2015-308576. Epub 2016 Feb 8.

PMID:
26857213
38.

Epicardial myocardial strain abnormalities may identify the earliest stages of arrhythmogenic cardiomyopathy.

Réant P, Hauer AD, Castelletti S, Pantazis A, Rosmini S, Cheang MH, Peyrou J, Tomé-Esteban M, Syrris P, Lafitte S, Moon JC, McKenna WJ.

Int J Cardiovasc Imaging. 2016 Apr;32(4):593-601. doi: 10.1007/s10554-015-0813-9. Epub 2015 Nov 25.

PMID:
26608801
39.

Successful launch of a comprehensive European registry for the cardiomyopathies.

Keren A, McKenna WJ.

Eur Heart J. 2016 Jan 7;37(2):174-6. doi: 10.1093/eurheartj/ehv539. Epub 2015 Nov 17. No abstract available.

PMID:
26578196
40.

Diagnostic yield of molecular autopsy in patients with sudden arrhythmic death syndrome using targeted exome sequencing.

Nunn LM, Lopes LR, Syrris P, Murphy C, Plagnol V, Firman E, Dalageorgou C, Zorio E, Domingo D, Murday V, Findlay I, Duncan A, Carr-White G, Robert L, Bueser T, Langman C, Fynn SP, Goddard M, White A, Bundgaard H, Ferrero-Miliani L, Wheeldon N, Suvarna SK, O'Beirne A, Lowe MD, McKenna WJ, Elliott PM, Lambiase PD.

Europace. 2016 Jun;18(6):888-96. doi: 10.1093/europace/euv285. Epub 2015 Oct 25.

41.

Use of high-throughput targeted exome-sequencing to screen for copy number variation in hypertrophic cardiomyopathy.

Lopes LR, Murphy C, Syrris P, Dalageorgou C, McKenna WJ, Elliott PM, Plagnol V.

Eur J Med Genet. 2015 Nov;58(11):611-6. doi: 10.1016/j.ejmg.2015.10.001. Epub 2015 Oct 9.

PMID:
26455666
42.

Feasibility and significance of preclinical diagnosis in hypertrophic cardiomyopathy.

Efthimiadis GK, Pagourelias ED, Hadjimiltiades S, Meditskou S, Karvounis H, McKenna WJ.

Cardiol Rev. 2015 Nov-Dec;23(6):297-302. doi: 10.1097/CRD.0000000000000076. Review.

PMID:
26440533
43.

Standing on the Shoulders of Giants: J.A.P. Paré and the Birth of Cardiovascular Genetics.

Sen-Chowdhry S, McKenna WJ.

Can J Cardiol. 2015 Nov;31(11):1305-8. doi: 10.1016/j.cjca.2015.05.026. Epub 2015 Jun 17.

PMID:
26440511
44.

Cardiopulmonary Exercise Testing and Prognosis in Hypertrophic Cardiomyopathy.

Coats CJ, Rantell K, Bartnik A, Patel A, Mist B, McKenna WJ, Elliott PM.

Circ Heart Fail. 2015 Nov;8(6):1022-31. doi: 10.1161/CIRCHEARTFAILURE.114.002248. Epub 2015 Sep 15.

PMID:
26374874
45.

Myocarditis and the military patient.

Cox AT, White S, Ayalew Y, Boos C, Haworth K, McKenna WJ.

J R Army Med Corps. 2015 Sep;161(3):275-82. doi: 10.1136/jramc-2015-000500. Epub 2015 Aug 5. Review.

PMID:
26246350
46.

Abnormal septal convexity into the left ventricle occurs in subclinical hypertrophic cardiomyopathy.

Reant P, Captur G, Mirabel M, Nasis A, M Sado D, Maestrini V, Castelletti S, Manisty C, Herrey AS, Syrris P, Tome-Esteban M, Jenkins S, Elliott PM, McKenna WJ, Moon JC.

J Cardiovasc Magn Reson. 2015 Jul 30;17:64. doi: 10.1186/s12968-015-0160-y.

47.

Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an international task force consensus statement.

Corrado D, Wichter T, Link MS, Hauer R, Marchlinski F, Anastasakis A, Bauce B, Basso C, Brunckhorst C, Tsatsopoulou A, Tandri H, Paul M, Schmied C, Pelliccia A, Duru F, Protonotarios N, Estes NA 3rd, McKenna WJ, Thiene G, Marcus FI, Calkins H.

Eur Heart J. 2015 Dec 7;36(46):3227-37. doi: 10.1093/eurheartj/ehv162. Epub 2015 Jul 27. Review. No abstract available.

48.

Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: An International Task Force Consensus Statement.

Corrado D, Wichter T, Link MS, Hauer RN, Marchlinski FE, Anastasakis A, Bauce B, Basso C, Brunckhorst C, Tsatsopoulou A, Tandri H, Paul M, Schmied C, Pelliccia A, Duru F, Protonotarios N, Estes NM 3rd, McKenna WJ, Thiene G, Marcus FI, Calkins H.

Circulation. 2015 Aug 4;132(5):441-53. doi: 10.1161/CIRCULATIONAHA.115.017944. Epub 2015 Jul 27. No abstract available.

49.

Prediction of thrombo-embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk-CVA).

Guttmann OP, Pavlou M, O'Mahony C, Monserrat L, Anastasakis A, Rapezzi C, Biagini E, Gimeno JR, Limongelli G, Garcia-Pavia P, McKenna WJ, Omar RZ, Elliott PM; Hypertrophic Cardiomyopathy Outcomes Investigators.

Eur J Heart Fail. 2015 Aug;17(8):837-45. doi: 10.1002/ejhf.316. Epub 2015 Jul 16.

50.

Clinical Significance of Epsilon Waves in Arrhythmogenic Cardiomyopathy.

Protonotarios A, Anastasakis A, Tsatsopoulou A, Antoniades L, Prappa E, Syrris P, Tousoulis D, McKENNA WJ, Protonotarios N.

J Cardiovasc Electrophysiol. 2015 Nov;26(11):1204-1210. doi: 10.1111/jce.12755. Epub 2015 Sep 6.

PMID:
26183028

Supplemental Content

Loading ...
Support Center